Qiu‐Xia Qu

916 total citations
33 papers, 734 citations indexed

About

Qiu‐Xia Qu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Qiu‐Xia Qu has authored 33 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 20 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Qiu‐Xia Qu's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (8 papers). Qiu‐Xia Qu is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (8 papers). Qiu‐Xia Qu collaborates with scholars based in China and United States. Qiu‐Xia Qu's co-authors include Xueguang Zhang, Yu Shen, Jian‐An Huang, Yibei Zhu, Cheng Chen, Wenwen Du, Cheng Chen, Zeyi Liu, Weiwei Ning and Jianjie Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Qiu‐Xia Qu

29 papers receiving 729 citations

Peers

Countries citing papers authored by Qiu‐Xia Qu

Since Specialization

Citations

This map shows the geographic impact of Qiu‐Xia Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiu‐Xia Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiu‐Xia Qu more than expected).

Fields of papers citing papers by Qiu‐Xia Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiu‐Xia Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiu‐Xia Qu. The network helps show where Qiu‐Xia Qu may publish in the future.

Co-authorship network of co-authors of Qiu‐Xia Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiu‐Xia Qu. A scholar is included among the top collaborators of Qiu‐Xia Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiu‐Xia Qu. Qiu‐Xia Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High CD38 expression defines a mitochondrial function-adapted CD8+ T cell subset with implications for lung cancer immunotherapy 2025 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), (unknown), (unknown), Yaoxin Zhang, Yu Shen, Qiu‐Xia Qu, Cheng Chen	3
2	B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer 2025 ·Frontiers in Immunology ·Yang Zhang, Yang Yang, Yuanyuan Zeng, Qiu‐Xia Qu, (unknown), Chuanyong Mu, Lei Wei, (unknown), (unknown), Lirong Gao, Zeyi Liu, (unknown), (unknown)	0
3	Combining local cryoablation with PD-L1 blockade synergistically eradicates established murine lung cancer by modulating mitochondrial in PD-1+CD8+ T cell 2023 ·Immunology Letters ·(unknown), (unknown), (unknown), (unknown), Yu Shen, Qiu‐Xia Qu, Cheng Chen	5
4	No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation 2023 ·Expert Review of Vaccines ·Ting Du, Qiu‐Xia Qu, Yawen Zhang, (unknown)	1
5	The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1+ regulator B cells mediates immunosuppression in triple-negative breast cancer 2022 ·Frontiers in Immunology ·Xuejiao Li, Huan Du, Shenghua Zhan, Wenting Liu, Zhangyu Wang, Jing Lan, (unknown), (unknown), Qiu‐Xia Qu, Sining Wang, Yang Yang, Qin Wang, Fang Xie	23
6	MiR‐106b inhibition suppresses inflammatory bone destruction of wear debris‐induced periprosthetic osteolysis in rats 2020 ·Journal of Cellular and Molecular Medicine ·Binqing Yu, Jiaxiang Bai, Jian Qing Shi, (unknown), Xiaobin Guo, Yu Liu, Gaoran Ge, Jiayi Lin, Yunxia Tao, Huilin Yang, Yaozeng Xu, Qiu‐Xia Qu, Dechun Geng	12
7	IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses 2020 ·Frontiers in Immunology ·Qiu‐Xia Qu, Zhiwei Zhai, Jieni Xu, Song Li, Cheng Chen, Binfeng Lu	21
8	4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation 2020 ·Frontiers in Immunology ·Qiu‐Xia Qu, (unknown), Wenwen Du, Hongbin Wang, (unknown), Yibei Zhu, Cheng Chen	24
9	Analysis of B7-H4 expression in metastatic pleural adenocarcinoma and therapeutic potential of its antagonists 2017 ·BMC Cancer ·Cheng Chen, Qiu‐Xia Qu, Fang Xie, Weidong Zhu, Yehan Zhu, Jianan Huang	6
10	PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer 2017 ·International Journal of Clinical Oncology ·(unknown), Yuanyuan Zeng, Qiu‐Xia Qu, Jianjie Zhu, Zeyi Liu, Weiwei Ning, Hui Zeng, Nan Zhang, Wenwen Du, Cheng Chen, Jian-An Huang	249
11	The increase of circulating PD-L1-expressing CD68+ macrophage in ovarian cancer 2015 ·Tumor Biology ·Qiu‐Xia Qu, Qin Huang, Yu Shen, Yibei Zhu, Xueguang Zhang	48
12	Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response 2012 ·Experimental Cell Research ·Cheng Chen, Yu Shen, Qiu‐Xia Qu, Xuqin Chen, Xueguang Zhang, Jian‐An Huang	88
13	ANALYSIS OF CD8⁺CD28⁻T-SUPPRESSOR CELLS IN GASTRIC CANCER PATIENTS 2012 ·Journal of Immunoassay and Immunochemistry ·Yu Shen, Qiu‐Xia Qu, Yibei Zhu, Xueguang Zhang	10
14	Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: A potential mechanism of immune escape 2011 ·Cancer Letters ·Cheng Chen, Qiu‐Xia Qu, Yu Shen, Chuanyong Mu, Yibei Zhu, Xueguang Zhang, Jian‐An Huang	76
15	CD40 is overexpressed by HPV16/18-E6 positive cervical carcinoma and correlated with clinical parameters and vascular density 2011 ·Cancer Epidemiology ·Qin Huang, Qiu‐Xia Qu, Fang Xie, Ting Zhang, Jianming Hu, Youguo Chen, Xueguang Zhang	11
16	Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma 2010 ·Medical Oncology ·Qin Huang, Qiu‐Xia Qu, Fang Xie, Jianming Hu, Youguo Chen, Xueguang Zhang	7
17	Preparation and Characterization of a Novel Chimeric Antibody Against Human CD40 with the Potential to Inhibit Daudi Cell Proliferation 2009 ·Hybridoma ·Qiu‐Xia Qu, Yan Ge, Yongjin Chen, Cheng Chen, Yuhua Qiu, Xueguang Zhang	1
18	CD40-activated Apoptotic Tumor Cell-pulsed Dendritic Cell Could Potentially Elicit Antitumor Immune Response 2008 ·Journal of Immunotherapy ·Cheng Chen, Yibei Zhu, Qiu‐Xia Qu, Yan Ge, Jian‐An Huang, Yong Wang, Xueguang Zhang	8
19	Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells 2007 ·Immunobiology ·Cheng Chen, Qiu‐Xia Qu, Jian‐An Huang, Yibei Zhu, Yan Ge, Qin Wang, Xueguang Zhang	25
20	Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves’ disease 2006 ·Cytokine ·Qin Wang, Yongjing Chen, Fang Xie, Yan Ge, Lei Chen, (unknown), Qiu‐Xia Qu, Xuefeng Wang, Xueguang Zhang	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact